Related Experiment Videos
The UK accelerated immunisation programme and sudden unexpected death in infancy: case-control study.
P J Fleming1, P S Blair, M W Platt
1Institute of Child Health, Royal Hospital for Children, Bristol BS2 8BJ, United Kingdom.
BMJ (Clinical Research Ed.)
|April 6, 2001
Summary
Infant immunisation in the UK is not linked to sudden infant death syndrome (SIDS). In fact, vaccination appears to offer protection against SIDS, with no increased risk observed.
Area of Science:
- Pediatrics
- Immunology
- Public Health
Background:
- Concerns exist regarding the safety of accelerated infant immunisation programmes.
- The potential association between immunisation and sudden infant death syndrome (SIDS) requires thorough investigation.
Purpose of the Study:
- To determine if the UK's accelerated immunisation schedule is associated with SIDS.
- To adjust for potential confounding factors in the analysis of immunisation and SIDS risk.
Main Methods:
- A population-based case-control study was conducted from February 1993 to March 1996 in five English regions.
- Parental interviews were conducted for SIDS cases and matched controls.
- Immunisation status was verified through parental records.
Main Results:
- After controlling for confounding factors, immunisation uptake was associated with a reduced risk of SIDS (OR 0.45).
- This protective association became non-significant after further adjustment for sleeping environment factors (OR 0.67).
- No significant temporal association was found between SIDS and recent or long-term immunisation.
Conclusions:
- Infant immunisation does not increase the risk of sudden unexpected death.
- The findings suggest that immunisation may offer a protective effect against SIDS.